等待开盘 06-26 09:30:00 美东时间
+0.090
+0.62%
EUDA holds the exclusive global distributorship rights for Helixé products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on
06-01 18:07
EUDA Health Holdings Limited, a Singapore-based healthcare provider, initially received a notice from Nasdaq regarding its failure to meet the minimum market value requirement of $35 million over 32 consecutive business days. However, the company regained compliance on May 28, 2026, as its market value reached $35 million for ten consecutive days from May 13 to May 27, 2026. EUDA focuses on non-invasive healthcare in Singapore, Malaysia, and Chin...
06-01 10:00
Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...
05-07 01:05
EUDA Health Holdings Limited ("EUDA" and the "Company") received a written notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on April 23, 2026, indicating that the
04-27 18:10
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
MaxLinear Inc (MXL) shares jump 34.3% in pre-market trading after reporting strong Q1 results and giving high Q2 sales guidance. Other gainers include CAST, ITOC, LABT, FCHL, INTC, WKC, PDFS, and LNAI. Losers include AIXI, SKLZ, AUUD, and EUDA.
04-24 17:20
MaxLinear, Inc.涨32.76%;World Kinect Corporation涨25.32%;英特尔涨20.49%
04-24 09:01
EUDA Health Holdings Limited涨-12.57%;Medicus Pharma Ltd涨-9.18%;Amesite Inc.涨-9.03%
04-24 08:05
EUDA Health Holdings Limited will implement a 1-for-20 reverse stock split effective March 23, 2026. This will reduce the number of outstanding shares from approximately 50.3 million to 2.5 million. Warrants will be adjusted to reflect the split, with the exercise price increasing from $11.50 to $230.00. Shareholders' ownership percentages remain unchanged, and those holding paper certificates may exchange them for updated ones if desired. No act...
03-19 09:30
今日重点评级关注:Evercore ISI集团:维持Caribou Biosciences"跑赢大市"评级,目标价从11美元升至13美元;富国银行:上调uniQure评级至"超配",目标价从15美元升至60美元
03-10 15:05